| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/09/2006 | US7041304 Dissolving thermotropic liquid crystal and monomer in a solvent and then adding initiator, emulsifying the solution in presence of dispersion stabilizer and suspension polymerizing in presence of polymerization inhibitor |
| 05/09/2006 | US7041303 Use of moxonidine for postmyocardial infarction treatment |
| 05/09/2006 | US7041287 Comprises anticoagulant/thrombolytic agent for selective dissolution of fibrin clots |
| 05/09/2006 | US7041283 treating Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, Alzheimer's disease and stroke by transplanting human neuronal cells, which have been cultured with a FK506, cyclosporin A or rapamycin immunosuppressant having an affinity for immunophilins |
| 05/09/2006 | US7041277 Chewing gum and confectionery compositions with encapsulated stain removing agent compositions, and methods of making and using the same |
| 05/09/2006 | US7041244 Method for producing moulded bodies |
| 05/09/2006 | US7041241 Microspheres contain 5-fluorouracil coated with poly(d-l-lactic acid-co-glycolic acid); implanted in walls of operation site following exeresis of tumor, by intratissular injection |
| 05/09/2006 | US7041130 Stent for controlled release of drug |
| 05/09/2006 | US7040314 Aerosol generating devices and methods for generating aerosols suitable for forming propellant-free aerosols |
| 05/09/2006 | US7040313 Method and apparatus for nitric oxide generation |
| 05/09/2006 | US7040311 Closure-cap and container as a two-chamber cartridge for nebulizers for producing aerosols and active substance formulations, suitable for storage |
| 05/09/2006 | CA2395653C New inhalable powder containing tiotropium |
| 05/09/2006 | CA2346662C Compositions containing diphosphonic acids |
| 05/09/2006 | CA2322501C Processes for the preparation of (r)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
| 05/09/2006 | CA2246615C Biodegradable polymer networks for use in orthopedic and dental applications |
| 05/09/2006 | CA2180480C Method for preparing liposomes without using an organic solvent |
| 05/09/2006 | CA2173506C Enteric granule-containing tablets |
| 05/04/2006 | WO2006047738A2 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 05/04/2006 | WO2006047695A2 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 05/04/2006 | WO2006047693A2 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 05/04/2006 | WO2006047692A2 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 05/04/2006 | WO2006047690A2 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 05/04/2006 | WO2006047689A2 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 05/04/2006 | WO2006047688A2 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 05/04/2006 | WO2006047684A2 Tissue factor phospholipid vesicle particles and methods of use for coagulation |
| 05/04/2006 | WO2006047660A2 Methods of acoustic measurement and control of pharmaceutical sprays |
| 05/04/2006 | WO2006047590A2 Compositions and treatments of bacterial vaginosis |
| 05/04/2006 | WO2006047579A2 Vitamin e tpgs fluid concentrate comprising a low percentage of water |
| 05/04/2006 | WO2006047496A2 Biopolymeric membranes |
| 05/04/2006 | WO2006047493A2 Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
| 05/04/2006 | WO2006047409A2 Dermal delivery of n-methyl-glucamine and n-methyl-glucamine compounds |
| 05/04/2006 | WO2006047365A1 Pharmaceutical composition comprising diclofenac |
| 05/04/2006 | WO2006047362A2 Transdermal delivery systems |
| 05/04/2006 | WO2006047315A2 Targeted delivery of biological factors using self-assembling peptide nanofibers |
| 05/04/2006 | WO2006047279A2 In situ controlled release drug delivery system |
| 05/04/2006 | WO2006047227A1 Compositions and methods for treatment of hypertrophic tissues |
| 05/04/2006 | WO2006047068A1 Non-blooming gelatin and non-gelatin formulations |
| 05/04/2006 | WO2006047067A1 Tablets comprising a poorly compressible active agent and tocopherol polyethyleneglycol succinate (tpgs) |
| 05/04/2006 | WO2006046958A1 Decongestant and expectorant system |
| 05/04/2006 | WO2006046933A1 Sedative and spasmolytic medicinal agent and method for the production thereof (variants) |
| 05/04/2006 | WO2006046623A1 Solid medicinal preparation improved in solubility and stability and process for producing the same |
| 05/04/2006 | WO2006046560A1 Propiverine-containing oral particulate preparation and process for producing the same |
| 05/04/2006 | WO2006046527A1 Solid pharmaceutical preparation dissolved in oral cavity |
| 05/04/2006 | WO2006046256A1 Extended release formulation of pramipexole dihydrochloride |
| 05/04/2006 | WO2006046234A2 System and apparatus for multi media surveillance |
| 05/04/2006 | WO2006046155A2 Loadable polyphosphazene-comprising particles for therapeutic and/or diagnostic applications and methods of preparing and using the same |
| 05/04/2006 | WO2006046114A2 Osmotic dosage forms providing ascending drug release, and processes for their preparation |
| 05/04/2006 | WO2006046111A1 Use of xylitol as an anti-chalk acting agent in compositions for oral use containing a calcium-containing compound as an active substance |
| 05/04/2006 | WO2006046109A1 Process for forming amorphous atorvastatin |
| 05/04/2006 | WO2006046105A1 Oxcarbazepine dosage forms |
| 05/04/2006 | WO2006046100A1 Pharmaceutical composition of alendronic acid |
| 05/04/2006 | WO2006046041A1 New pharmaceutical formulations useful in the treatment of insomnia |
| 05/04/2006 | WO2006045870A1 Orally-dispersible pharmaceutical compositions |
| 05/04/2006 | WO2006045865A1 Pharmaceutical formulation comprising microcapusles of statins suspended in alkyl esters of polyunsaturated fatty acids (pufa) |
| 05/04/2006 | WO2006045830A1 A highly porous, fast-disintegrating solid dosage form and its way of manufacturing comprising the preparation of a podwer and a freezedrying step |
| 05/04/2006 | WO2006045618A1 Dosage form time-lagged of drugs for the therapy of insomnia |
| 05/04/2006 | WO2006045532A2 Virosome particles comprising antigens from influenza virus and hepatitis b virus |
| 05/04/2006 | WO2006045512A1 Solid pharmaceutical composition comprising donepezil hydrochloride |
| 05/04/2006 | WO2006045152A1 Improved tabletting process |
| 05/04/2006 | WO2006038931A3 Odor-reducing quinone compounds |
| 05/04/2006 | WO2006030297B1 Taste masked granules comprising clarithromycin, hydrocolloids and a coating |
| 05/04/2006 | WO2006024949A3 Controlled release dosage forms combining immediate release and sustained release of low-solubility drug |
| 05/04/2006 | WO2006015299A3 Multi-reservoir device for transdermal drug delivery and sensing |
| 05/04/2006 | WO2006013376A3 Drug delivery of a cox inhibitor from embolic agents |
| 05/04/2006 | WO2006008320A3 Device for transdermal delivery of active principles |
| 05/04/2006 | WO2006007402A3 Poly (lactid acid) copolymer hydrogels and related methods of drug delivery |
| 05/04/2006 | WO2005115432A3 Treatment of ocular diseases and disorders using lantibiotic compositions |
| 05/04/2006 | WO2005115336A3 Sprayable formulations for the treatment of acute inflammatory skin conditions |
| 05/04/2006 | WO2005115332A3 Heat sterilization of glucocorticosteroids |
| 05/04/2006 | WO2005115110A3 Oral products |
| 05/04/2006 | WO2005113236A3 Films comprising a liquid-absorbant inner layer, an antimicrobial material and an impermeable outer layer |
| 05/04/2006 | WO2005112902A3 Medicinal aerosol formulation products with improved chemical stability |
| 05/04/2006 | WO2005112891A3 Encapsulated transfer factor compositions and methods of use |
| 05/04/2006 | WO2005112546A3 Mucinous glycoprotein (muc-1) vaccine |
| 05/04/2006 | WO2005110448A3 Nutritional composition for increasing creatine uptake in skeletal muscle |
| 05/04/2006 | WO2005110395A8 System and device for magnetic drug targeting with magnetic drug carrier particles |
| 05/04/2006 | WO2005105043A3 Pharmaceutical compositions |
| 05/04/2006 | WO2005099668A3 Methods of manufacture and use of calcium phosphate particles containing allergens |
| 05/04/2006 | WO2005097083A3 Transdermal administration of proton pump inhibitors |
| 05/04/2006 | WO2005094786A3 Coated tablet formulation and method |
| 05/04/2006 | WO2005070398A8 Pharmaceutical compositions of candesartan cilexetil stabilized with co-solvents |
| 05/04/2006 | WO2005053657A3 Coated tablet containing venlafaxin or its salts with controlled release |
| 05/04/2006 | WO2005030169A8 Methods for preparing oil bodies comprising active ingredients |
| 05/04/2006 | WO2005025543A3 Polymer-based sustained release device and method for preparation |
| 05/04/2006 | US20060095021 Introduction of agent with medical device |
| 05/04/2006 | US20060095020 Introduction of agent with medical device |
| 05/04/2006 | US20060094816 Processes for preparing energy-curable emulsions and processes for coating substrates therewith |
| 05/04/2006 | US20060094787 Pharmaceutical composition comprising 5-methyl-2-2'(chloro-6'-fluoroanilino) phenylacetic acid |
| 05/04/2006 | US20060094782 Compositions and dosage forms for enhanced absorption |
| 05/04/2006 | US20060094775 Remedy for corneal ulcer |
| 05/04/2006 | US20060094721 Sulfonamides as potassium channel blockers |
| 05/04/2006 | US20060094698 Self-administered contraceptive injection of oily solution |
| 05/04/2006 | US20060094665 Pharmaceutical angiostatic dipeptide compositions and methods of use thereof |
| 05/04/2006 | US20060094643 Compositions of hyaluronic acid and methods of use |
| 05/04/2006 | US20060094608 Mixture of polyol and insulation agent; heating upon exposure to moisture; for urogenital systems; dysmenorrhea |
| 05/04/2006 | US20060094032 iRNA agents targeting VEGF |
| 05/04/2006 | US20060093680 Coated particles and pharmaceutical dosage forms |
| 05/04/2006 | US20060093679 Fast releasing, solid administration form for oral application of active ingredients which are hard to dissolve |
| 05/04/2006 | US20060093678 Methods for making pharmaceutical formulations comprising deagglomerated microparticles |
| 05/04/2006 | US20060093677 Methods for making pharmaceutical formulations comprising deagglomerated microparticles |